Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Capital Expenditures (2024)

Historic Capital Expenditures for Fennec Pharmaceuticals (FENC) over the last 4 years, with Q1 2024 value amounting to $1.7 million.

  • Fennec Pharmaceuticals' Capital Expenditures changed N/A to $1.7 million in Q1 2024 from the same period last year, while for Jun 2024 it was $1.7 million, marking a year-over-year change of. This contributed to the annual value of $175000.0 for FY2022, which is N/A changed from last year.
  • Per Fennec Pharmaceuticals' latest filing, its Capital Expenditures stood at $1.7 million for Q1 2024.
  • Fennec Pharmaceuticals' 5-year Capital Expenditures high stood at $1.7 million for Q1 2024, and its period low was $1.7 million during Q1 2024.